These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10070508)

  • 1. Delays in the diagnosis of uveal melanoma and effect on treatment.
    Ah-Fat FG; Damato BE
    Eye (Lond); 1998; 12 ( Pt 5)():781-2. PubMed ID: 10070508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to treatment of uveal melanoma in the United Kingdom.
    Damato B
    Eye (Lond); 2001 Apr; 15(Pt 2):155-8. PubMed ID: 11339581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients.
    Damato EM; Damato BE
    Ophthalmology; 2012 Aug; 119(8):1582-9. PubMed ID: 22503229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
    Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
    Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nondiagnosed uveal melanomas.
    Bove R; Char DH
    Ophthalmology; 2004 Mar; 111(3):554-7. PubMed ID: 15019335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventable delays in the treatment of intraocular melanoma in the UK.
    Holden R; Damato BE
    Eye (Lond); 1996; 10 ( Pt 1)():127-9. PubMed ID: 8763318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary transpupillary thermotherapy for 18 small posterior pole uveal melanomas.
    Spire M; Devouassoux MS; Kodjikian L; Janin-Magnificat H; Fleury J; Grange JD
    Am J Ophthalmol; 2006 May; 141(5):840-849. PubMed ID: 16678505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.